CIK: 0001652044 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 1, 2025
Total Value ($000): $2,135,230 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASTS | AST SPACEMOBILE INC | 8,943,486 | $417,929 | 19.6% | $25.58 | +13.2% | COM CL A | 00217D100 |
| ARM | ARM HOLDINGS PLC | 1,960,784 | $317,137 | 14.9% | $53.52 | — | SPONSORED ADS | 042068205 |
| FRSH | FRESHWORKS INC | 16,206,643 | $241,641 | 11.3% | $22.50 | -36.0% | CLASS A COM | 358054104 |
| PL | PLANET LABS PBC | 31,942,641 | $194,850 | 9.1% | $9.47 | -56.9% | COM CL A | 72703X106 |
| RVMD | REVOLUTION MEDICINES INC | 4,133,277 | $152,063 | 7.1% | $24.03 | +59.9% | COM | 76155X100 |
| — | METSERA INC | 4,961,744 | $141,162 | 6.6% | $27.22 | — | COM | 59267L107 |
| — | VERVE THERAPEUTICS INC | 12,168,489 | $136,652 | 6.4% | $53.50 | — | COM | 92539P101 |
| GTLB | GITLAB INC | 2,724,712 | $122,912 | 5.8% | $59.42 | -23.0% | CLASS A COM | 37637K108 |
| TEM | TEMPUS AI INC | 1,551,102 | $98,557 | 4.6% | $30.66 | +87.0% | CL A | 88023B103 |
| DXCM | DEXCOM INC | 1,036,937 | $90,514 | 4.2% | $99.11 | -20.9% | COM | 252131107 |
| PATH | UIPATH INC | 7,034,337 | $90,040 | 4.2% | $73.33 | -83.6% | CL A | 90364P105 |
| PRME | PRIME MEDICINE INC | 15,062,498 | $37,204 | 1.7% | $15.84 | -90.3% | COM | 74168J101 |
| MAZE | MAZE THERAPEUTICS INC | 2,412,471 | $29,601 | 1.4% | $12.04 | -13.6% | COM | 578784100 |
| OSCR | OSCAR HEALTH INC | 481,988 | $10,334 | 0.5% | $31.30 | -52.5% | CL A | 687793109 |
| SANA | SANA BIOTECHNOLOGY INC | 2,812,500 | $7,678 | 0.4% | $32.56 | -93.7% | COM | 799566104 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 1,464,015 | $6,603 | 0.3% | $20.37 | -78.1% | COM | 61225M102 |
| VERA | VERA THERAPEUTICS INC | 241,264 | $5,684 | 0.3% | $15.54 | +44.7% | CL A | 92337R101 |
| BEAM | BEAM THERAPEUTICS INC | 321,604 | $5,470 | 0.3% | $21.73 | -19.9% | COM | 07373V105 |
| RLAY | RELAY THERAPEUTICS INC | 1,568,753 | $5,428 | 0.3% | $37.40 | -92.0% | COM | 75943R102 |
| DNTH | DIANTHUS THERAPEUTICS INC | 208,697 | $3,888 | 0.2% | $12.62 | +48.7% | COM | 252828108 |
| LYEL | LYELL IMMUNOPHARMA INC | 293,256 | $2,592 | 0.1% | $9.11 | 0.0% | COM NEW | 55083R203 |
| SPRO | SPERO THERAPEUTICS INC | 889,979 | $2,581 | 0.1% | $12.27 | -88.3% | COM | 84833T103 |
| FHTX | FOGHORN THERAPEUTICS INC | 500,901 | $2,354 | 0.1% | $19.16 | -78.2% | COM | 344174107 |
| WGS | GENEDX HOLDINGS CORP | 22,711 | $2,096 | 0.1% | $33.78 | +132.4% | COM | 81663L200 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 698,262 | $1,592 | 0.1% | $26.79 | — | SPON ADS | 05280R100 |
| TCRX | TSCAN THERAPEUTICS INC | 1,077,080 | $1,562 | 0.1% | $9.27 | -84.4% | COM | 89854M101 |
| TSHA | TAYSHA GENE THERAPIES INC | 640,882 | $1,480 | 0.1% | $23.52 | -90.8% | COM SHS | 877619106 |
| BRNS | BARINTHUS BIOTHERAPEUTICS PL | 1,513,644 | $1,408 | 0.1% | $16.78 | — | ADS | 91864C107 |
| EXAS | EXACT SCIENCES CORP | 23,205 | $1,233 | 0.1% | $105.58 | -51.9% | COM | 30063P105 |
| GUTS | FRACTYL HEALTH INC | 662,584 | $1,073 | 0.1% | $8.42 | -80.8% | COM | 35168W103 |
| HYPR | HYPERFINE INC | 898,720 | $647 | 0.0% | $9.78 | -92.8% | COM CL A | 44916K106 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $559 | 0.0% | $21.49 | -97.6% | COM | 87990A106 |
| QNCX | QUINCE THERAPEUTICS INC | 189,122 | $312 | 0.0% | $29.87 | -96.2% | COM | 22053A107 |
| ALEC | ALECTOR INC | 175,866 | $246 | 0.0% | $18.92 | -93.4% | COM | 014442107 |
| FULC | FULCRUM THERAPEUTICS INC | 14,262 | $98 | 0.0% | $11.14 | -52.0% | COM | 359616109 |
| RGEN | REPLIGEN CORP | 383 | $48 | 0.0% | $269.41 | -52.8% | COM | 759916109 |